Fellowship Programs
Infectious Diseases Fellowship
Infectious disease has been a key area of investigation since the founding of UC-Davis Medical Center. Our founding chief, Paul Hoeprich, M.D. wrote the first comprehensive textbook on Infectious Diseases. In the late 1980s and the 1990s, UC Davis scientists, including faculty from the Division of Infectious Diseases, played important roles in understanding HIV infection, AIDS, and other retroviral infections by identifying simian and feline immunodeficiency viruses. Our faculty, along with others at UC Davis, advanced knowledge of the natural history of both the AIDS viruses, including mechanisms of cross-species transmission and the role of the immune systems in fighting these viruses. Our current division chief, Dr. Stuart Cohen, is a leading expert in the pathogenesis and epidemiology of Clostridium difficile disease, and the first-author of the current IDSA C. difficile guidelines. Dr. George Thompson, fellowship director, is the managing editor and second-author of the 2016 IDSA Aspergillosis Guidelines, and the 2020 Endemic Mycoses Guidelines.
Ongoing research efforts within the division span the breadth of infectious diseases. Members of the division have developed bioengineered stem cells that generate an HIV-resistant immune system in transplant recipients and human clinical trials have recently begun. Other areas of active clinical and laboratory research include hepatitis B and C, Clostridium difficile and H. pylori, invasive fungal infections, transplant medicine, infection control, and antibiotic stewardship. Department faculty members pursuing research in infectious diseases are associated with many other departments in our Schools of Medicine, including:
- Veterinary Medicine
- Center for Immunology and Infectious Diseases
- California National Primate Research Center
- Mouse Biology Program
- Mutant Mouse Pathology Laboratory
- Comprehensive Cancer Center
- Center for Biophotonics
- UC Health System Epidemiology Collaborative, and others.
Infectious Diseases IDI 460
Course Description:
Patients ill with infectious diseases, including AIDS, will be evaluated and presented at rounds and case conferences. Patients are also seen in the Infectious Diseases Clinic and OCH clinic. Instruction in clinical microbiology and the proper use of the laboratory will be provided.
Common Problems/Diseases Encountered:
Common areas of disease encountered would be General Infectious Diseases and HIV/AIDS. Other areas of service would be consulting with Orthopedics and Trauma on Bone Infections; Neurosurgery for Meningitis; Hematology/Oncology on Neutropenic Patients; and Antibiotic Stewardship for all services.
Common Procedures Performed / Observed:
Procedures are not performed with this consult service. Antibiotic Stewardship for all services.
Comments:
Students may elect to do a 4 week rotation if space allows. Additional didactic sessions are available during weekly Journal Club and Case Conference. Students are allowed 1 absence for interviews and/or personal reasons. Please contact the Student Coordinator, Marissa E Valentin-Clark with any questions. mevclark@ucdavis.edu
| Class of 2024 |
| War War Ko, M.D. Residency: St. John’s Episcopal Hospital |
| Aishan Shi, M.D. Residency: Banner University of Arizona Tucson |
| Kimrey Van Perre, M.D. Residency: Loma Linda University Medical Center |
| Class of 2023 |
| Malik Darwish, M.D. Residency: University of Pittsburgh Medical Center |
| Gerald Hutfles, D.O. Residency: Providence Portland Medical Center |
| Laya Reddy, M.D. Residency: Scripps Green Hospital and Scripps Clinic |
| Class of 2022 | |
| Gauri Barlingay, M.B.B.S | Banner Desert, Mesa, AZ |
| Derek Bays, M.D. | UC Davis Medical Center, Sacramento, CA *UC Davis Medical Center Fellow of the Year Award Winner |
| Minh-Vu Hoang Nguyen, M.D., M,Sc, | National Jewish Health, Denver, CO *UC Davis Department of Internal Medicine Trainee Research Award (Fellow, 2020) |
| Class of 2021 | |
| Kaitlyn Hardin, M.D. | UC Davis Medical Center, Sacramento, CA |
| Class of 2020 | |
| Archana Reddy, M.D. | UC Davis Medical Center, Sacramento, CA |
| Janet Yang, M.D. | Sacramento VA Medical Center, Mather, CA |
| Class of 2019 | |
| Melony Chakrabarty, M.D. | UC Davis Medical Center, Sacramento, CA |
| Anne Spichler Moffarah, M.D. | Yale School of Medicine, New Haven, CT |
| Class of 2018 | |
| Nathaniel DeFelice, M.D. | Sutter Health, Roseville, CA |
| Bruce Weng, D.O. | Riverside University Health System Medical Center, Moreno Valley, CA *UC Davis Medical Center Fellow of the Year Award Winner |
| Class of 2017 | |
| Jillian Ahrens, M.D. | Clinical Team Lead for Nurx, A Telehealth Company |
| Rie Ueno, M.D. | Merck Inc., Tokyo, Japan |
| Class of 2016 | |
| Ethan Stewart, M.D. | Kaiser, San Diego, CA |
| Sarah Waldman, M.D. | UC Davis Medical Center, Sacramento, CA |
| Class of 2015 | |
| Priya Nand, M.D. | Dignity Health, Stockton, CA |
| Meryl Twarog Perez, M.D. | Pulmonary Medical Associates, Sacramento, CA |
| Class of 2014 | |
| Matthew Eldridge, M.D. | Kaiser, South Sacramento, CA |
| Lenora Lee, M.D. | Kaiser, Sacramento, CA |
| Class of 2013 | |
| Sanaz Abderrahmane, M.D. | Mercy Medical Group, Sacramento, CA |
| Bhavna Malik, M.D. | Sutter Health, Walnut Creek, CA |
| Class of 2012 | |
| Sharon Wang, D.O. | Arrowhead Regional Medical Center, Colton, CA |
| Shiv Sudhakar, M.D. | Palo Alto VA Medical Center, Menlo Park, CA |
| Class of 2011 | |
| Jevon Tang, M.D. | Washington Hospital, Fremont, CA |
| Eric Shigeno, M.D. | St. Joseph Health Mission Hospital, Mission Viejo, CA |
| Class of 2010 | |
| Jennifer Brown, M.D. | UC Davis Medical Center, Sacramento, CA |
| Phillip Cole, M.D. | Amplyx Pharmaceuticals, San Diego, CA |
| Class of 2009 | |
| Erin Hsu, M.D. | Sutter Health, San Francisco, CA |
| Robert Eison, M.D. | Colorado Infectious Diseases, Denver, CO |
*100% Board Pass rate over the last 10 years
- McHardy I, Reagan KL, Sebastian JF, Barker B, Bays DJ, Dandekar S, Cohen SH, Jennings KE, Sykes J, Thompson GR III. Sex Differences in Susceptibility to Coccidioidomycosis. Open Forum Infect Dis. 2022 Feb 16;9(3):ofab543. doi: 10.1093/ofid/ofab543. PMID: 35252466.
-
Bays DJ, Thompson GR, Reef S, Snyder L, Freifeld AJ, Huppert M, Salkin D, Wilson MD, Galgiani JN. Natural History of Disseminated Coccidioidomycosis: Examination of the Veterans Affairs-Armed Forces Database. Clin Infect Dis. 2021 Dec 6;73(11):e3814-e3819. doi: 10.1093/cid/ciaa1154. PMID: 32778863.
- Bays DJ, Thompson GR III. Coccidioidomycosis. Infect Dis Clin North Am. 2021 Jun;35(2):453-469. doi: 10.1016/j.idc.2021.03.010. PMID: 34016286.
- Davis MR, Nguyen M-VH, Gintjee TJ, Odermatt A, Young BY, Thompson GR. Management of posaconazole-induced pseudohyperaldosteronism. J Antimicrob Chemother. 2020 Dec 1;75(12):3688-3693. doi: 10.1093/jac/dkaa366. PMID: 32830274.
- Sanville B, Corbett R, Pidcock W, Hardin K, Sebat C, Nguyen M-VH, Thompson GR, Haczku A, Schivo M, Cohen S. A Community-transmitted Case of Severe Acute Respiratory Distress Syndrome (SARS) Due to SARS-CoV-2 in the United States. Clin Infect Dis. 2020 Nov 19;71(16):2222-2226. doi: 10.1093/cid/ciaa347. PMID: 32227197; PMCID: PMC7197621.
- Nguyen M-VH, Wiederhold NP, Cañete-Gibas C, Sanders C, Thompson GR 3rd. Spiromastigoides asexualis: Phylogenetic Analysis and Evaluation as a Cause of False-Positive Blastomyces DNA Probe Test Results. J Clin Microbiol. 2020 Nov 18;58(12):e01325-20. doi: 10.1128/JCM.01325-20. PMID: 32907993; PMCID: PMC7685880.
- Odermatt A, Nguyen M-VH, Thompson GR. Reply to DiPippo and Kontoyiannis. Clin Infect Dis. 2020 Jul 11;71(2):469. doi: 10.1093/cid/ciz945. PMID: 31674647.
- Bays D, Nguyen M-VH, Cohen S, Waldman S, Martin C, Thompson G,...Penn B. Investigation of Nosocomial SARS-CoV-2 Transmission from Two Patients to Health Care Workers Identifies Close Contact but not Airborne Transmission Events. Infection Control & Hospital Epidemiology. 2020;1-22. doi:10.1017/ice.2020.321. PMID: 32618530.
- Nguyen M-VH, Davis MR, Wittenberg R, Mchardy I, Baddley JW, Young BY, Odermatt A, Thompson GR III. Posaconazole Serum Drug Levels Associated with Pseudohyperaldosteronism. Clinical Infectious Diseases. 2020;70(12):2593-2598. doi:10.1093/cid/ciz741. PMID: 31403165.
- Nguyen M-VH, Giordani MM, Thompson GR III. The Double-Edged Sword - Prosthetic Joint Infection Following BCG Treatment for Bladder Cancer: a case report. BMC Infectious Diseases. 2019 Apr 18;19(1):331. doi: 10.1186/s12879-019-3951-1. PMID: 30999879.
- Bays DJ, Thompson GR III. Fungal Infections of the Stem Cell Transplant Recipient and Hematologic Malignancy Patients. Infectious Diseases Clinics of North America. 2019 Jun;33(2):545-566. doi: 10.1016/j.idc.2019.02.006. PMID: 31005138.
- Davis MR, Nguyen M-VH, Donnelley MA, Thompson GR III. Tolerability of Long-Term Fluconazole in Patients with Coccidioidomycosis. Journal of Antimicrobial Chemotherapy. 2019 Mar 1;74(3):768-771. doi: 10.1093/jac/dky501. PMID: 30535104.
- Nguyen M-VH, Levy NS, Ahuja SD, Trieu L, Proops DC, Achkar JM. Factors Associated With Sputum Culture-Negative vs Culture-Positive Diagnosis of Pulmonary Tuberculosis. JAMA Netw Open. 2019 Feb 1;2(2):e187617. doi: 10.1001/jamanetworkopen.2018.7617. PMID: 30735231; PMCID: PMC6484588.
- McHardy I, Dinh BT, Waldman S, Stewart E, Bays D, Pappagianis D, Thompson GR III. Coccidioidomycosis Complement Fixation Titer Trends in the Age of Antifungals. Journal of Clinical Microbiology. 2018 Nov 27;56(12). doi: 10.1128/JCM.01318-18. PMID: 30257902.
- Ling JL, Bays DJ, Thompson GR III, Moshiri A, Mannis MJ. Favorable Outcome in Coccidioides endophthalmitis – a Combined Medical and Surgical Treatment Approach. Cornea. 2017 Nov;36(11):1423-1425. doi: 10.1097/ICO.0000000000001353. PMID: 28872517.
- Thompson GR III, Blair J, Wang S, Bercovitch R, Bolaris M, Van Den Akker D, Lopez R, Heidari A, Catanzaro A, Cadena J, Chin-Hong P, Spellberg B, Johnson R. Adjunctive Corticosteroid Therapy in the Treatment of Coccidioidal Meningitis. Clin Infect Dis. 2017 Apr 17. doi: 10.1093/cid/cix318. PMID: 28419259.
- Donnelley MA, Zhu ES, Thompson GR III. Isavuconazole in the treatment of invasive aspergillosis and mucormycosis infections. Infect Drug Resist. 2016 Jun 2;9:79-86. doi: 10.2147/IDR.S81416. PMID: 27330318.
- Polage CR, Gyorke CE, Kennedy MA, Leslie JL, Chin DL, Wang S, Nguyen HH, Huang B, Tang YW, Lee LW6, Kim K, Taylor S, Romano PS, Panacek EA, Goodell PB, Solnick JV, Cohen SH. Overdiagnosis of Clostridium difficile Infection in the Molecular Test Era. JAMA Intern Med. 2015 Nov;175(11):1792-801. doi: 10.1001/jamainternmed.2015.4114. PMID: 26348734.
- Nguyen M-VH, Jenny-Avital ER, Burger S, Leibert EM, Achkar JM. Clinical and Radiographic Manifestations of Sputum Culture-Negative Pulmonary Tuberculosis. PLoS One. 2015 Oct 8;10(10):e0140003. doi: 10.1371/journal.pone.0140003. PMID: 26448182; PMCID: PMC4598139.
- Thompson GR III, Albert N, Hodge G, Wilson MD, Sykes JE, Bays DJ, Firacative C, Meyer W, Kontoyiannis DP. Phenotypic Differences of Cryptococcus genotypes: implications for virulence in a Drosophila model of infection. Infection and Immunity. 2014 July;82(7):3058-3065. doi: 10.1128/IAI.01805-14. PMID: 24799631.
- Eldridge M, Cohen SH. Cutaneous manifestations of infection in returning travelers. Curr Infect Dis Rep. 2014 Oct;16(10):426. doi: 10.1007/s11908-014-0426-9. PMID: 25129114.
- Eldridge ML, Chambers CJ, Sharon VR, Thompson GR III. Fungal infections of the skin and nail: new treatment options. Expert Rev Anti Infect Ther. 2014 Nov;12(11):1389-405. doi: 10.1586/14787210.2014.960849. PMID: 25241767.
- Thompson GR III, Wang S, Bercovitch R, Bolaris M, Van Den Akker D, Taylor S, Lopez R, Catanzaro A, Cadena J, Chin-Hong P, Spellberg B. Routine CSF analysis in coccidioidomycosis is not required. PLoS One. 2013 May 22;8(5):e64249. doi: 10.1371/journal.pone.0064249. PMID: 23717579.
- Thompson GR III, Bays DJ, Taylor SL, Cohen SH, Pappagianis D. Association Between Serum 25-Hydroxyvitamin D Level and Type of Coccidioidal Infection. Medical Mycology. 2013 Apr;51(3):319-23. doi: 10.3109/13693786.2012.690536. PMID: 22680977.
- Thompson GR III, Sharma S, Bays DJ, Pruitt R, Engelthaler DM, Bowers J, Driebe EM, Davis M, Libke R, Cohen SH, Pappagianis D. Coccidioidomycosis: Adenosine Deaminase Levels, Serologic Parameters, Culture Results, and Polymerase Chain Reaction Testing in Pleural Fluid. CHEST. 2013 Mar;143(3):776-81. doi: 10.3109/13693786.2012.690536. PMID: 22680977.
- Thompson GR III, Bays DJ, Johnson SM, Cohen SH, Pappagianis D, Finkelman MA. Serum (1-->3)-β-D-Glucan Measurement in Coccidioidomycosis. Journal of Clinical Microbiology. 2012 Sep;50(9):3060-2. doi: 10.1128/JCM.00631-12. PMID: 22692738.
- Halilovic J, Heintz BH, Brown J. Risk factors for clinical failure in patients hospitalized with cellulitis and cutaneous abscess. J Infect. 2012 Aug;65(2):128-34. doi: 10.1016/j.jinf.2012.03.013. PMID: 22445732.
- Thompson GR III, Bays D, Cohen SH, Pappagianis D. Fluoride Excess in Coccidioidomycosis Patients Receiving Long-Term Antifungal Therapy: An assessment of currently available triazoles. Antimicrobial Agents and Chemotherapy. 2012 Jan;56(1):563-4. doi: 10.1128/AAC.05275-11. PMID: 22005993.
- Thompson GR III, Lunetta JM, Johnson SM, Taylor S, Bays D, Cohen SH, Pappagianis D. Early Treatment with Fluconazole may Abrogate the Development of IgG Antibodies in Coccidioidomycosis. Clinical Infectious Diseases. 2011; Sep;53(6):e20-4. doi: 10.1093/cid/cir466. PMID: 21865185.
- Berghout J, Thompson GR III, Bays DJ, Waldman S, Stewart E, Hsu A, Powell DA, Chaput AL, Pouladi N, Vitali F, Shubitz LF, Holland SM, Frelinger JA, Galgiani JN, Lussier YA. Identification of Rare Variants Contributing to Disseminated Coccidioidomycosis Susceptibility After Infection. University of Arizona Genetics Program – “Is it In Your Genes?”. Tucson, AZ: Nov 20th, 2019. Poster # pending.
- Bays DJ, Thompson GR III, Freifeld AJ, Reef S, Synder L, Huppert M, Salkin D, Galgiani JN. The Natural History of Chronic Pulmonary Coccidioidomycosis in the Pre-Antifungal Era. In: IDWeek 2019. Programs and Abstracts of the 54th Annual Infectious Diseases Society of America (IDSA) Meeting. Washington D.C.: October 4th, 2019. Poster # pending.
- Berghout J, Thompson GR III, Bays DJ, Waldman S, Stewart E, Hsu A, Powell DA, Chaput AL, Pouladi N, Vitali F, Shubitz LF, Holland SM, Frelinger JA, Galgiani JN, Lussier YA. Identification of Rare Variants Contributing to Disseminated Coccidioidomycosis Susceptibility After Infection. American Society of Human Genetics. Houston, TX: Oct 19th, 2019. Abstract #1921354
- Nguyen MV, Davis M, Wittenberg R, McHardy I, Baddley J, Young B, Odermatt A, Thompson GR III. Posaconazole Serum Drug Levels Associated with Hypertension and Hypokalemia: The Syndrome of Pseudohyperaldosteronism. In: 9th Trends in Medical Mycology (TIMM). Nice, France: October 13th, 2019. Poster #088.
- Nguyen MVH, Davis MR, Wittenberg R, Mchardy I, Baddley JW, Young BY, Odermatt A, Thompson GR III. Posaconazole Serum Drug Levels Associated with Pseudohyperaldosteronism. In: IDWeek 2019. Programs and Abstracts of the 54th Annual Infectious Diseases Society of America (IDSA) Meeting. Washington D.C.: October 4th, 2019. Poster # pending.
- Nguyen MV, Davis M, Donnelley M, Wittenberg R, Thompson GR III. Posaconazole-Induced Apparent Mineralocorticoid Excess. In: Coccidioidomycosis Study Group. Programs and Abstracts of the 63rd Annual Meeting. Sacramento, CA: April 6th, 2019. Selected for Oral Presentation.
- Davis M, Nguyen MV, Donnelley M, Thompson GR III. Tolerability of long-term fluconazole therapy. In: Coccidioidomycosis Study Group. Programs and Abstracts of the 63rd Annual Meeting. Sacramento, CA: April 6th, 2019. Selected for Oral Presentation.
- Bays DJ, Thompson GR III, Freifeld AJ, Reef S, Snyder L, Huppert M, Salkin D, Galgiani JN. An Examination of Chronic Pulmonary Coccidioidomycosis in the Pre-Antifungal Era. In: Coccidioidomycosis Study Group. Programs and Abstracts of the 63rd Annual Meeting. Sacramento, CA: April 6th, 2019. Selected for Oral Presentation.
- Mchardy I, Dinh BT, Bays DJ, Waldman S, Stewart E, Pappagianis D, Thompson GR III. New Observations in Coccidioidomycosis Serology. In: IDWeek 2018. Programs and Abstracts of the 54th Annual Infectious Diseases Society of America (IDSA) Meeting. San Francisco, CA: October 4th, 2018. Poster #388.
- Bays DJ, Thompson GR III, Reef S, Snyder L, Freifeld AJ, Huppert M, Salkin D, Wilson MD, Galgiani JN. A Reexamination of Disseminated Coccidioidomycosis: The Natural History in the Pre-Antifungal Era. In: IDWeek 2018. Programs and Abstracts of the 54th Annual Infectious Diseases Society of America (IDSA) Meeting. San Francisco, CA: October 4th, 2018. Poster #386.
- Davis MR, Nguyen MVH, Donnelley MA, Thompson GR III. Long-Term Fluconazole Tolerability and Efficacy in Patients with Coccidioidomycosis. In: IDWeek 2018. Programs and Abstracts of the 54th Annual Infectious Diseases Society of America (IDSA) Meeting. San Francisco, CA: October 4th, 2018. Poster #392.
- Bays DJ, Thompson GR III, Reef S, Synder L, Freifeld AJ, Huppert M, Salkin D, Wilson MW, Galgiani JN. Disseminated Coccidioidomycosis in the Pre-amphotericin Era: Examination of the VA-Armed Forces Database. In: Coccidioidomycosis Study Group. Programs and Abstracts of the 62nd Annual Meeting. Flagstaff, AZ: April 14th, 2018.
- Bays DJ, Thompson GR III, Reef S, Snyder L, Huppert M, Salkin D, Galgiani J. Natural History of Non-CNS Disseminated Coccidioidomycosis. In: IDWeek 2017. Programs and Abstracts of the 54th Annual Infectious Diseases Society of America (IDSA) Meeting. San Diego, CA: October 5th, 2017. Poster #157.
- Thompson GR III, Wang S, Bercovitch R, Bolaris M, Van Den Akker D, Lopez R, Heidan A, Catanzaro A, Cadena J, Chin-Hong P, Spellberg B, Blair J, Johnson R. Adjunctive Corticosteroid in the Treatment of Coccidioidal Meningitis, In: IDWeek 2015. Programs and Abstracts of the 52nd Annual Infectious Diseases Society of America (IDSA) Meeting. San Diego, CA: October 2017. Poster #1459.
- Nand P, Cohen SH, Wilson M, Brown J. Curbing Antimicrobial Resistance: Do Physicians Receive Adequate Training About Antibiograms? In: Society for Healthcare Epidemiology of America (SHEA). Orlando, FL: May 2015. Abstract #7002.
- Thompson GR III, Albert N, Hodge G, Sykes J, Bays D, Firacative C, Meyer W, Kontoyiannis D. Phenotypic differences of Cryptococcus gattii genotypes: implications for virulence in a Drosophila model of infection. In: Programs and Abstracts of the 51st Annual Meeting of the Infectious Diseases Society of America (IDSA) Meeting. San Francisco, CA: Selected for Oral Presentation. Session #1824.
- Eldridge M, Cohen SH, Thompson GR III. Treatment of Refractory Coccidioidomycosis with Liposomal Amphotericin B. In: Programs and Abstracts of the 51st Annual Infectious Diseases Society of America (IDSA) Meeting. San Francisco, CA: October 2013. Presentation #M-222.
- Thompson GR III, Sykes J, Ding K, Hodge G, Bays DJ, Firacative C, Albert N, Meyer W, Kontoyiannis DP. Virulence of different Cryptococcus gattii genotypes in a Drosophila melanogaster model of infection. In: IDWeek. Programs and Abstracts of the 50th Annual Infectious Diseases Society of America (IDSA) Meeting. San Diego, CA: 2012. Poster #127. *Featured on Poster Walk. Highlighting the top abstracts presented at IDSA 2012.
- Thompson GR III, Sharma S, Bays DJ, Pruitt R, Engelthaler DM, Bowers J, Driebe E, Libke R, Cohen S, Pappagianis D. Pleural Effusions Caused by Coccidioidomycosis: ADA levels, serologic parameters, culture results and PCR testing. In: IDWeek. Programs and Abstracts of the 50th Annual Infectious Diseases Society of America (IDSA) Meeting. San Diego, CA: 2012. Poster #138.
- Thompson GR III, Bays D, Sharma S, Davis M, Libke R, Pappagianis D. Diagnostic Value of Adenosine Deaminase Levels in Lymphocytic Pleural Effusions Caused by Coccidioidomycosis. In: Programs and Abstracts of the 56th Annual Coccidioidomycosis Study Group. Tuscon, AZ: 2012.
- Thompson GR III, Bays D, Sharma S, Davis M, Libke RD, Pappagianis D. Adenosine Deaminase Levels in Pleural Effusions Caused by Coccidioidomycosis. In: Programs and Abstracts of the 49th Annual Infectious Diseases Society of America (IDSA) Meeting. Boston, MA: Poster #1049.
- Thompson GR III, Bays D, Pruitt R, Cohen S, Pappagianis D. Association Between Serum 25-Hydroxyvitamin D Level and Type of Coccidioidal Infection. In: Programs and Abstracts of the 49th Annual Infectious Diseases Society of America (IDSA) Meeting. Boston, MA: Poster #1053.
- Thompson GR III, Wang S, Bercovitch R, Bolaris M, Spier A, Taylor S, Lopez R, Catanzaro A, Cadena J, Chin-Hong P, Spellberg B. Routine CSF Analysis Based on Coccidioidal CF Antibody Titers: Evidence Based Practice or Dogma? In: Programs and Abstracts of the 49th Annual Infectious Diseases Society of America (IDSA) Meeting. Boston, MA: Presentation #963.
- Thompson GR III, Singer L, Bays D, Meyer W, Lindsay LL, Sykes JE. Differences in Antifungal Susceptibility Among Molecular Types of Cryptococcus gattii. In: Programs and Abstracts of the 8th International Conference on Cryptococcus and Cryptococcosis (ICCC). Charleston, SC: 2011.
- Thompson GR III, Lunetta JM, Bays D, Johnson SM, Cohen SH, Pappagianis D. Early Treatment with Fluconazole may Abrogate the Development of IgG Antibodies in Coccidioidomycosis. In: Programs and Abstracts of the 48th Annual Infectious Diseases Society of America (IDSA) Meeting. Vancouver, Canada: Poster #660.
Below is an example of the schedule for years 1-2 as an Infectious Diseases Fellow.
| VA Hospital | 10 weeks | 16 weeks |
| Transplant Consults & Antimicrobial Stewardship | 6 weeks | 4 weeks |
| One Community Health (HIV Clinic) | Once weekly | Once weekly |
| Travel Medicine Clinic | 8 clinics | 8 clinics |
| Education Days (Conferences, etc.) | 4 days | 4 days |
| Vacation | 20 days | 20 days |
| Wellness Days | 2 Half Days | 2 Half Days |
*A third year of fellowship is available for those desiring additional training for the development of an academic/research career.
Changes effective January 1, 2020
A Postgraduate Training License (PTL) will be required for ALL RESIDENTS participating in a California ACGME program for the first 36 months of any ACGME training
- A trainee must obtain a PTL within 180 days after enrollment in the program
- After the first 36 months of any ACGME training Residents/Fellows MUST obtain a full and unrestricted California medical license.
- The PTL will be valid until 90 days after completion of the first 36 months of any ACGME training (to allow an applicant time to obtain a full and unrestricted license)
- A PTAL will no longer be required for International Medical Graduates (IMG)
All residents and fellows are REQUIRED to have a full and unrestricted California Medical License after they complete 36 months of any ACGME (or RCPSC, CFPC) program training
California Licensure Requirements:
- 36 months of ACGME training (ACGME-International Training is not applicable)
- At least 24 consecutive months of ACGME training
- in the same ACGME program
- within the first 36 months of training
- If a candidate does not meet this criterion, they may not train in California beyond 36 total months under any circumstances
- ACGME-International Training is not applicable for a California Medical License
Applicants may (should) submit the PTL application and supporting documents soon as they have confirmation of acceptance into the ACGME program
